Outlook Therapeutics Inc (Outlook Therapeutics Inc (OTLK)) has gained Wednesday morning, with the stock rising 14.78% in pre-market trading to 1.32.
OTLK's short-term technical score of 17 indicates that the stock has traded less bullishly over the last month than 83% of stocks on the market. In the Biotechnology industry, which ranks 94 out of 146 industries, the stock ranks higher than 27% of stocks.
Outlook Therapeutics Inc has fallen 11.54% over the past month, closing at $1.22 on January 6. During this period of time, the stock fell as low as $0.94 and as high as $1.40. OTLK has an average analyst recommendation of Strong Buy. The company has an average price target of $5.00.
Outlook Therapeutics Inc has a Long-Term Technical rank of 23. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 77% of the market scoring higher. In the Biotechnology industry which is number 73 by this metric, OTLK ranks better than 33% of stocks.
Important Dates for Investors in OTLK:
-Outlook Therapeutics Inc is set to release earnings on 2/12/2021. During their last earnings release the company posted EPS of $-0.99. -We do not have a set dividend date for Outlook Therapeutics Inc at this time. Click Here to get the full Stock Score Report on Outlook Therapeutics Inc (OTLK) Stock.